Polyclonal Rabbit anti‑Human DNA Topoisomerase II Antibody (Biotin, aa923‑1148, WB) LS‑C685038
Polyclonal Rabbit anti‑Human DNA Topoisomerase II Antibody (Biotin, aa923‑1148, WB) LS‑C685038
Antibody:
DNA Topoisomerase II Rabbit anti-Human Polyclonal (aa923-1148) (Biotin) Antibody
Format:
Biotin, Unmodified
Overview
Antibody:
DNA Topoisomerase II Rabbit anti-Human Polyclonal (aa923-1148) (Biotin) Antibody
Format:
Biotin, Unmodified
Specifications
Description
DNA Topoisomerase II antibody LS-C685038 is a biotin-conjugated rabbit polyclonal antibody to human DNA Topoisomerase II (aa923-1148). Validated for WB.
Target
Human DNA Topoisomerase II
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Biotin.
Also available
Unconjugated or conjugated with
FITC,
Cy3,
HRP,
APC,
PE,
APC, Cy7.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant TOP2 (Ile923-Arg1148) expressed in E. coli.
Specificity
The antibody is a rabbit polyclonal antibody raised against TOP2.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
Western blot
Species:
Human, Monkey, Mouse, Rat, Bat, Bovine, Dog, Horse, Pig, Rabbit, Chicken, Xenopus
Applications:
IHC, IHC - Paraffin, Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Reactivity:
Mouse
Range:
0.625-40 ng/ml
Species:
Mouse
Applications:
Flow Cytometry
Reactivity:
Rat
Range:
0.312-20 ng/ml
Source:
Human
Tag:
Myc-DDK (Flag)
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/28/2024